Michael I Barbato
4PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 05, 2025
FDA Approval Summary: Vorasidenib for IDH-Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery.Michael I Barbato, Amy K Barone, Stephanie L Aungst
|Jun 14, 2024
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer.Michael I Barbato, Diana Bradford, Yi Ren
|Aug 23, 2023
FDA Approval Summary: Dabrafenib in Combination with Trametinib for BRAFV600E Mutation-Positive Low-Grade Glioma.Michael I Barbato, Jeannette Nashed, Diana Bradford
|Oct 27, 2022
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.John A Ligon, R Taylor Sundby, Mary F Wedekind
Pageof 1
Frequent Collaborators
3 joint publications
Richard Pazdur
3 joint publications
Nicole Drezner
3 joint publications
Paul G Kluetz
3 joint publications
Barbara Scepura
3 joint publications
Claudia P Miller
3 joint publications
Youwei Bi
2 joint publications
Hong Zhao
2 joint publications
Yangbing Li
2 joint publications
Pallavi S Mishra-Kalyani
2 joint publications
Yi Ren
